News
Stay informed about developments in drug policy and our latest media releases, research and publications.
-
Santé mentale
Read more: Santé mentaleCOVID-19 Santé mentale, COVID-19 Santé mentale Guides et recherche COVID-19 – Pandémie, bien-être et santé…
-
Gestion, RH et plus
Read more: Gestion, RH et plusCOVID-19 Gestion RH et plus, COVID-19 Gestion RH et plus Guides Meilleures pratiques pour prévenir…
-
Télétravail, cybersécurité et ergonomie
Read more: Télétravail, cybersécurité et ergonomieCOVID-19 Ergonomie et télétravail, COVID-19 Ergonomie et télétravail Guides Lignes directrices d’ergonomie en cas de…
-
Medications and clinical approaches to support physical distancing for PWUD
Read more: Medications and clinical approaches to support physical distancing for PWUDThis is 1 of 6 guidance documents, developed by CRISM at the request of federal…
-
Supporting people who use drugs in acute care settings during COVID-19
Read more: Supporting people who use drugs in acute care settings during COVID-19This document is one of six guidance documents by the CRISM network at the request…
-
Reducing COVID-19 Spread in Recovery Programs & Treatment Services
Read more: Reducing COVID-19 Spread in Recovery Programs & Treatment ServicesThis document is 1 of 6 guidance documents developed by CRISM at the request of…
-
Telemedicine support for addiction services
Read more: Telemedicine support for addiction servicesThis document is 1 of 6 guidance documents developed by the CRISM network at the…
-
Expanded Response Options to Opioid Harms: Case Study from Four Cities
Read more: Expanded Response Options to Opioid Harms: Case Study from Four CitiesCOVID-19 pandemic compounds an ongoing public health crisis. There is a heightened need to reduce…
-
Harm Reduction and COVID-19 Guidance for Service Providers
Read more: Harm Reduction and COVID-19 Guidance for Service ProvidersGuidance for service providers on how to alter harm reduction practices during pandemic to reduce…
